SIRT3 & SIRT7: Potential Novel Biomarkers for Determining Outcome in Pancreatic Cancer Patients.

PLoS One · 2015 · PMC4487247 · PMID 26121130

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Conversely, patients who expressed high levels of SIRT3 and were treated with chemotherapy had a shorter time to relapse (14.3vs 30.7 months, p = 0.159) and death (18.3 vs 34.7 months, p = 0.148) than those who did not receive chemotherapy, though this did not reach statistical significance ( Fig 4C and 4D ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.